Supplementation With Lactoferrin in Preterm Newborns
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The main objective of the study is to evaluate the antioxidant effect of lactoferrin and its
ability to reduce free radicals related diseases in the newborn. This evaluation will be done
through the assessment of neuro-developmental follow-up.
The secondary objective is to identify a panel of markers for assessing oxidative stress and
for a correlation with the lactoferrin antioxidant effect.